PR NEWS: $MFTH Medisafe 1 Technologies Records an Operating Profit of Approximately $2M in the Fourth Fiscal Quarter of 2012 01/14 08:02 AM
--------------------------------------------------------------------------------
JERUSALEM, January 14, 2013 /PRNewswire/ --
Medisafe 1 Technologies Corp. (MFTH:$0.002,0$0.0003,17.65%) , a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company has generated an operating profit of approximately $2M in its fourth fiscal quarter from the sale of its first non-exclusive perpetual license agreement that transfers rights for the full commercialization, marketing and distribution of its patented medicinal locking mechanism and bar-code matching system.
Rights to a third party
"Upon the completion of this non-exclusive perpetual license agreement, we will be extremely pleased to be able to reward our shareholders with this special dividend," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp. (MFTH:$0.002,0$0.0003,17.65%) "Similarly, we intend to continue to update our shareholders with further information following the sale's closing."
About Medisafe 1 Technologies (MFTH:$0.002,0$0.0003,17.65%)
Medisafe 1 Technologies (MFTH:$0.002,0$0.0003,17.65%) seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Â Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.
AI
